Luc Lammens
Director of Finance/CFO at Apitope International NV
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hayley French | M | - |
Apitope International NV
 Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | 14 years |
| David Wraith | M | - |
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | 22 years |
| Stéphane Verdood | M | - |
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | - |
| Tom Aerts | M | - |
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | - |
| Lotta Jansson | M | - |
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | - |
| Colin Dayan | M | - |
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Koen Lamberts | M | - |
Katholieke Universiteit Leuven
| 8 years |
| Dirk Gyselinck | M | 58 |
Katholieke Universiteit Leuven
| 5 years |
| Hilde Windels | F | 59 |
Katholieke Universiteit Leuven
| 1 years |
| Rudi op ‘t Roodt | M | 61 |
Katholieke Universiteit Leuven
| 4 years |
| Kurt C. Staelens | M | 54 |
Katholieke Universiteit Leuven
| 4 years |
| Steven Vanackere | M | 60 |
Katholieke Universiteit Leuven
| 2 years |
| Christiaan Peeters | M | - |
Katholieke Universiteit Leuven
| 2 years |
| Karya Budiana | M | - |
Katholieke Universiteit Leuven
| 1 years |
| Koen Algoed | M | 59 |
Katholieke Universiteit Leuven
| 1 years |
| Frederic Cecile Jean Hubert Hendrickx | M | - |
Katholieke Universiteit Leuven
| 4 years |
| Nadia Bervaes | F | - |
Katholieke Universiteit Leuven
| 4 years |
| Lieven Cooreman | M | 59 |
Katholieke Universiteit Leuven
| 4 years |
| Anne Frederix | M | 59 |
Katholieke Universiteit Leuven
| 3 years |
| Jean Paul Abrams | M | 61 |
Katholieke Universiteit Leuven
| 1 years |
| Raymund Trost | M | - |
Katholieke Universiteit Leuven
| 1 years |
| Carl Dotremont | M | - |
Katholieke Universiteit Leuven
| 5 years |
| Bart Boesmans | M | 60 |
Katholieke Universiteit Leuven
| 1 years |
| Alexandre Mottrie | M | - |
Katholieke Universiteit Leuven
| 4 years |
| Patty Terryn | M | - |
Katholieke Universiteit Leuven
| 5 years |
| Marc Verstraete | M | 54 |
Katholieke Universiteit Leuven
| 4 years |
| Michiel S. J. Steyaert | M | - |
Katholieke Universiteit Leuven
| 3 years |
| André-Xavier Cooreman | M | 60 |
Katholieke Universiteit Leuven
| 3 years |
| Annick van Overstraeten | F | 58 |
Katholieke Universiteit Leuven
| 4 years |
| Joost L. van Meerbeeck | M | - |
Katholieke Universiteit Leuven
| 3 years |
| Bart de Moor | M | 63 |
Katholieke Universiteit Leuven
| 3 years |
| Jan de Witte | M | 59 |
Katholieke Universiteit Leuven
| 1 years |
| Wim Goemaere | M | - |
Katholieke Universiteit Leuven
| 1 years |
| Setio Anggoro Dewo | M | 62 |
Katholieke Universiteit Leuven
| 2 years |
| Pieter Robrecht Bevernage | M | 56 |
Katholieke Universiteit Leuven
| 3 years |
| Wouter Devriendt | M | 57 |
Katholieke Universiteit Leuven
| 1 years |
| Chang Qi Wu | M | 69 |
Katholieke Universiteit Leuven
| 3 years |
| Harjono Wreksoremboko | M | 61 |
Katholieke Universiteit Leuven
| 2 years |
| Marc Stephan Louis Louette | M | 58 |
Katholieke Universiteit Leuven
| 1 years |
| Michel van Geyte | M | 58 |
Katholieke Universiteit Leuven
| 2 years |
| Ruud Joosten | M | 59 |
Katholieke Universiteit Leuven
| 2 years |
| Werner Geurts | M | - |
Katholieke Universiteit Leuven
| 1 years |
| Sonja de Becker | F | 57 |
Katholieke Universiteit Leuven
| 3 years |
| Yu Zhong Wang | M | 75 |
Katholieke Universiteit Leuven
| 1 years |
| David Suetens | M | - |
Katholieke Universiteit Leuven
| 5 years |
| Bart de Groote | M | - |
Katholieke Universiteit Leuven
| 4 years |
| Katleen Vandeweyer | F | 55 |
Katholieke Universiteit Leuven
| 4 years |
| Carolien D'Hauwers | F | - |
Katholieke Universiteit Leuven
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Belgium | 48 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Luc Lammens
- Personal Network
